Page 1 2 ... 30 40 50 ... 200 ... NEXT>>
[ February 13, 2016 | Author: Admin | Views: 23577 | Weather: | Mood: normal]

Unlike ConocoPhillips (COP), Hess’s (HES) dividend wasn’t big enough to move the needle if cut. So it’s selling stock instead: Bloomberg News Hess has priced the concurrent offering of ~28.8mm shares of common stock and ~11.5mm depositary shares, assuming the over-allotment options are exercised. The depositary shares represent a 1/20th interest in each share of Hess 8% Mandatory Convertible Preferred Stock, which unless converted earlier at the option of the holder will convert on or around February 1st, 2019 into Hess common shares. Based on the equity offering price of $39/share, we estimate total net proceeds of ~$1.65bn net common offering proceeds of $1.09bn and net depositary share offering proceeds of ~$558mm. The offerings represent ~10% of Hess prior outstanding share count and ~15% on fully diluted basis including the conversion of the convertible preferred shares. Top New Stocks To Own Right Now: Home Federal Bancorp Inc.(HOME) Home Federal Bancorp, … Continue reading

[ February 13, 2016 | Author: Admin | Views: 25555 | Weather: | Mood: normal]

JPMorgan’s Cory Kasimov and team offer their advice on playing the biotech selloff, which has continued today with the iShares Nasdaq Biotechnology ETF (IBB) having tumbled more than 3% today: Biotech stocks remain volatile and are down meaningfully relative to the broader markets (Nasdaq Biotech Index: -22%; S&P 500 -6%) with the Big 4 clearly outperforming the group (down only 8-15% YTD) but still underperforming the market, and many SMIDs are off 25-50%. To put this move in context, theNasdaq Biotech Index is now trading at levels not seen since the fall of 2014; moreover, large-cap biotech multiples are down to 13x 2016 consensus EPS vs. 16x for the S&P and 17x for major pharma. We maintain that fundamentals have not meaningfully changed (broadly speaking), and this move is largely the result of fund flows in the midst of a messy macro backdrop and after a multi-year run of outperformance … Continue reading

[ February 13, 2016 | Author: Admin | Views: 8354 | Weather: | Mood: normal]

If youre among the one in five Americans making a lifestyle choice to avoid gluten — a protein found in wheat, rye, and barley — or the one in 100 Americans diagnosed with celiac disease, which prohibits gluten intake, youve likely seen your food costs go up. SEE ALSO: The Most-Overlooked Tax Deductions Restaurants often charge more for gluten-free pizza crust or pasta, for example. And at the grocery store, we found a Freschetta five-cheese medley pizza for $7.99, compared with the gluten-free version at $10.99. Likewise, a box of regular Betty Crocker yellow cake mix costs $1.59, while the gluten-free version is $4.69. Did you know you might be eligible for a tax break to help offset some of those costs? The weight-loss area of the tax law offers guidance for restricted diets, says Mark Luscombe, principal federal tax analyst for Wolters Kluwer Tax & Accounting US. That says … Continue reading

[ February 13, 2016 | Author: Admin | Views: 7341 | Weather: | Mood: normal]

Intel’s freeD and Curie technologies are changing how we watch sports. Did he score or not? Was she in or out of bounds? Despite multiple cameras covering major events, we still miss a lot of stuff when watching sports. We’re still not sure if the player was down before he fumbled. We missed the awesome pass, because the big guy was blocking our view of it. Intel is helping to change our view of sports with the introduction of two new technologies: Curie and freeD. If you were watching Super Bowl 50 earlier this month, then you’ve seen freeD in action. When the offense scored a touchdown (all two of them!) CBS showed a 360-degree shot of the play, letting you see the TD from virtually any angle. FreeD will also be on display during Sunday’s NBA All-Star Game. TNT, owned by CNNMoney parent company Turner, will place 28 cameras … Continue reading

[ February 13, 2016 | Author: Admin | Views: 84782 | Weather: | Mood: normal]

When a good mutual fund does well, everyone takes notice. But its easy to overlook a formerly poor performer that has turned the corner. Take the three Vanguard funds described below. Once mediocre, they have turned things around in recent years. See Also: 9 Great Vanguard Funds for Retirement Savers For context, compare the returns of these funds with those of Standard & Poors 500-stock index, in parentheses below. Results are through January 29 and are annualized. Vanguard Growth & Income Fund Symbol: (VQNPX) Assets: $6.2 billion Expense ratio: 0.34% One-year return: -2.4% (S&P 500: -0.7%) Three-year return: 11.4% (S&P 500: 11.3%) Five-year return: 11.5% (S&P 500: 11.5%) 10-year return: 5.7% (S&P 500: 5.7%) Hot Long Term Stocks To Watch For 2016: Brookline Bancorp Inc.(BRKL) Brookline Bancorp, Inc. operates as the holding company for Brookline Bank, Bank Rhode Island, and The First National Bank of Ipswich, which provide commercial and … Continue reading